Scleromyxoedema: clinical follow-up after successful treatment with high-dose immunoglobulins reveals different long-term outcomes

Acta Derm Venereol. 2012 Jul;92(4):408-9. doi: 10.2340/00015555-1299.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Female
  • Humans
  • Immunoglobulins, Intravenous / therapeutic use*
  • Immunologic Factors / therapeutic use*
  • Middle Aged
  • Recurrence
  • Remission Induction
  • Scleromyxedema / diagnosis
  • Scleromyxedema / drug therapy*
  • Scleromyxedema / pathology
  • Skin / drug effects
  • Skin / pathology
  • Time Factors
  • Treatment Outcome

Substances

  • Immunoglobulins, Intravenous
  • Immunologic Factors